ATE192438T1 - Bis-2-aminopyridine, verfahren zu ihrer herstelung und ihre verwendung zur bekämpfung von parasitosen - Google Patents

Bis-2-aminopyridine, verfahren zu ihrer herstelung und ihre verwendung zur bekämpfung von parasitosen

Info

Publication number
ATE192438T1
ATE192438T1 AT95935490T AT95935490T ATE192438T1 AT E192438 T1 ATE192438 T1 AT E192438T1 AT 95935490 T AT95935490 T AT 95935490T AT 95935490 T AT95935490 T AT 95935490T AT E192438 T1 ATE192438 T1 AT E192438T1
Authority
AT
Austria
Prior art keywords
pct
aminopyridines
bis
controlling
parasitosis
Prior art date
Application number
AT95935490T
Other languages
English (en)
Inventor
Henri Vial
Michele Calas
Jean-Jacques Bourguignon
Marie-Laure Ancelin
Louis Giral
Original Assignee
Virbac Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac Sa filed Critical Virbac Sa
Application granted granted Critical
Publication of ATE192438T1 publication Critical patent/ATE192438T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95935490T 1994-10-14 1995-10-13 Bis-2-aminopyridine, verfahren zu ihrer herstelung und ihre verwendung zur bekämpfung von parasitosen ATE192438T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9412301A FR2725718B1 (fr) 1994-10-14 1994-10-14 Bis-2-aminopyridines, leur procede de preparation et leurs applications
PCT/FR1995/001349 WO1996011910A1 (fr) 1994-10-14 1995-10-13 Bis-2-aminopyridines, leur procede de preparation et leurs applications contre les parasitoses

Publications (1)

Publication Number Publication Date
ATE192438T1 true ATE192438T1 (de) 2000-05-15

Family

ID=9467876

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95935490T ATE192438T1 (de) 1994-10-14 1995-10-13 Bis-2-aminopyridine, verfahren zu ihrer herstelung und ihre verwendung zur bekämpfung von parasitosen

Country Status (9)

Country Link
US (1) US5834491A (de)
EP (1) EP0785924B1 (de)
JP (1) JP3873173B2 (de)
AT (1) ATE192438T1 (de)
AU (1) AU3749195A (de)
DE (1) DE69516706T2 (de)
ES (1) ES2148570T3 (de)
FR (1) FR2725718B1 (de)
WO (1) WO1996011910A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096788A (en) * 1996-07-31 2000-08-01 Virbac S.A. Antimalaria and antibabesiosis agents and pharmaceutical compositions containing such agents
FR2751967B1 (fr) * 1996-07-31 1998-10-09 Virbac Sa Agents antipaludeens et antibabesioses et compositions pharmaceutiques les contenant
US20060025458A1 (en) * 2004-07-30 2006-02-02 University Of Connecticut Alkylammonium compounds as antifungal and antitrypanosomal agents
US8932842B2 (en) 2009-02-11 2015-01-13 Northwestern University Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
US8278084B2 (en) 2009-02-11 2012-10-02 Northwestern University Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
JP7268049B2 (ja) 2018-03-08 2023-05-02 インサイト・コーポレイション ＰＩ３Ｋ－γ阻害剤としてのアミノピラジンジオール化合物
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206215A (en) * 1976-02-25 1980-06-03 Sterling Drug Inc. Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes
GB9100465D0 (en) * 1991-01-09 1991-02-20 Hider Robert C Pharmaceutical compositions

Also Published As

Publication number Publication date
US5834491A (en) 1998-11-10
JP3873173B2 (ja) 2007-01-24
WO1996011910A1 (fr) 1996-04-25
DE69516706D1 (de) 2000-06-08
FR2725718A1 (fr) 1996-04-19
ES2148570T3 (es) 2000-10-16
AU3749195A (en) 1996-05-06
FR2725718B1 (fr) 1997-01-24
JPH10507446A (ja) 1998-07-21
EP0785924A1 (de) 1997-07-30
DE69516706T2 (de) 2000-11-23
EP0785924B1 (de) 2000-05-03

Similar Documents

Publication Publication Date Title
RU2159761C2 (ru) Замещенные 4-биарилмасляные или 5-биарилпентановые кислоты или их производные, способы их получения, фармацевтическая композиция и способ лечения
DE69429078D1 (de) Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
DE59409794D1 (de) Benzoylguanidine, ihre herstellung und ihre verwendung in arzneimitteln
ATE175201T1 (de) Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DZ1794A1 (fr) Nouvelle formule pharmaceutique.
ATE212993T1 (de) Pyrolopyrimidine und verfahren zu ihrer herstellung
DE59510042D1 (de) 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz
ATE152448T1 (de) Heterozyklische alkylamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE219499T1 (de) Lipopeptid-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE59608203D1 (de) PYRAZOLO- 1,5a]-PYRIMIDINE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG
DE69504509D1 (de) Thiazolidinderivate, ihre herstellung und medikamente, die sie enthalten
DE69632194D1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
ATE192438T1 (de) Bis-2-aminopyridine, verfahren zu ihrer herstelung und ihre verwendung zur bekämpfung von parasitosen
ATE85334T1 (de) Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung.
EP0268223A3 (de) Optisch aktive Gyrasehemmer, ihre Herstellung und Verwendung als Antibiotika
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE59507531D1 (de) Cyclohexanon-derivate, verfahren zu deren herstellung und zwischenprodukte des verfahrens
ATE69809T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten.
ATE195529T1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DE59504643D1 (de) Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
ATE66468T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten.
ATE141593T1 (de) Leukotrien-b 4?-derivative, verfahren zu ihrer herstellung und arzneimittel
NO974687L (no) Kondenserte <beta>-carboliner
ATE62688T1 (de) Benzylaminoaryl-dihydropyridinelactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties